Protein detail

CD2

T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)

Entry name
CD2
UniProt ID
EVMP score
0.50
Frequency
1
Transmembrane count
1
Protein classification
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2)
Protein Class
CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins
Protein Function
  • CD markers
  • Predicted intracellular proteins
  • FDA approved drug targets:Biotech drugs
Transmembrane
210..235; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym
SRBC
Gene Description
CD2 molecule
Chromosome
1
Position
116754430-116769229
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
CD2 fluorescence
Tissue Specificskin 1Cell SpecificDistal convoluted tubule cellsSingle-Nuclei Brain Specificchoroid plexus epithelial cellBlood Cell SpecificT-reg
Function & Pathway
Relations & Evidence

Enzyme-Mediated Modification

0 records.

Ligand-Receptor Signaling

50 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
cell_surfacecell_surfaceBaccin2019NoNoNoYesNo
cell_surfacecell_surfaceOmniPathNoNoNoYesNo
receptorreceptorCellinkerNoYesNoYesNo
receptorreceptorscConnectNoYesNoYesNo
receptorreceptorconnectomeDB2020NoYesNoYesNo
receptorreceptorCellCellInteractionsNoYesNoYesNo
transmembranetransmembrane_predictedPhobiusNoNoNoYesNo
transmembrane_phobiustransmembrane_predictedAlmen2009NoNoNoYesNo
transmembrane_sosuitransmembrane_predictedAlmen2009NoNoNoYesNo
transmembrane_tmhmmtransmembrane_predictedAlmen2009NoNoNoYesNo
Page 5 of 5Previous

Regulatory Interaction Network

0 records.

Protein Complex Composition

130 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
ABCD1ABCD2LSM1LSM3LSM4LSM5LSM6LSM7LSM8PRPF3PRPF4SART3SNRPD3SNRPNTXNL4AO15116O43172O43395O95777P33897P62310P62312P62318P63162P83876Q15020Q9UBJ2Q9UK45Q9Y4Y9Q9Y4Z01:1:1:1:1:1:1:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC3887
BRCA2FANCD2FANCEFANCGO15287P51587Q9BXW9Q9HB961:1:1:1CompleatCFinderCompleat:HC5684
DDX3YEWSR1KLHL12NUDCD2O15523Q01844Q53G59Q8WVJ20:0:0:0hu.MAP2
DDX3YEWSR1NUDCD2O15523Q01844Q8WVJ20:0:0hu.MAP2
COA7DDX3YNUDCD2UBQLN2ZMYM3O15523Q14202Q8WVJ2Q96BR5Q9UHD90:0:0:0:0hu.MAP2
DDX3YNUDCD2O15523Q8WVJ20:0hu.MAP2
DDX17DDX21DHX15FUSGPATCH4NHP2NOP10PDCD2LPINX1SUMO1SUMO2TCOF1UBCO43143P0CG48P35637P61956P63165Q13428Q5T3I0Q92841Q96BK5Q9BRP1Q9NPE3Q9NR30Q9NX241:1:1:1:1:1:1:1:1:1:1:1:1NetworkBlastCompleatCompleat:HC6444
CCDC97CD2BP2CPSF6DDX23NUDT21PHF5APLRG1PRPF3PRPF31PRPF4PRPF6SART1SF3A1SF3A2SF3A3SF3B1SF3B2SF3B3SF3B4SF3B5SF3B6SMNDC1SNRNP40SNRPA1SNRPB2SNRPD1SNRPD2USP39O43172O43290O43395O43660O43809O75533O75940O94906O95400P08579P09661P62314P62316Q12874Q13435Q15393Q15427Q15428Q15459Q16630Q53GS9Q7RTV0Q8WWY3Q96DI7Q96F63Q9BUQ8Q9BWJ5Q9Y3B40:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0hu.MAP
CCDC97CD2BP2DDX23EFTUD2PHF5APQBP1PRPF3PRPF31PRPF4PRPF6PRPF8SART1SF3A1SF3A2SF3A3SF3B3SF3B4SF3B5SF3B6SNRNP200SNRNP40SNRPA1TFIP11USP39O43172O43290O43395O60828O75643O94906O95400P09661Q12874Q15029Q15393Q15427Q15428Q15459Q53GS9Q6P2Q9Q7RTV0Q8WWY3Q96DI7Q96F63Q9BUQ8Q9BWJ5Q9UBB9Q9Y3B40:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0:0hu.MAP
CD2BP2DDX23PQBP1PRPF3PRPF31PRPF4PRPF6PRPF8SART1SNRNP200SNRNP40TFIP11USP39WBP11O43172O43290O43395O60828O75643O94906O95400Q53GS9Q6P2Q9Q8WWY3Q96DI7Q9BUQ8Q9UBB9Q9Y2W20:0:0:0:0:0:0:0:0:0:0:0:0:0hu.MAP
Page 8 of 13PreviousNext

Isolation & Detection Technology

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationMass spectrometry123161513
Sequence, Structure & Domains

Sequences

Length
351
Mass
39,448
Sequence
MSFPCKFVASFLLIFNVSSKGAVSKEITNALETWGALGQDINLDIPSFQMSDDIDDIKWEKTSDKKKIAQFRKEKETFKEKDTYKLFKNGTLKIKHLKTDDQDIYKVSIYDTKGKNVLEKIFDLKIQERVSKPKISWTCINTTLTCEVMNGTDPELNLYQDGKHLKLSQRVITHKWTTSLSAKFKCTAGNKVSKESSVEPVSCPEKGLDIYLIIGICGGGSLLMVFVALLVFYITKRKKQRSRRNDEELETRAHRVATEERGRKPHQIPASTPQNPATSQHPPPPPGHRSQAPSHRPPPPGHRVQHQPQKRPPAPSGTQVHQQKGPPLPRPRVQPKPPHGAAENSLSPSSN

3D Structural Models

Turn
88..90; 139..142
Helix
62..64; 73..75; 99..101
Beta Strand
31..36; 41..43; 52..61; 67..71; 77..80; 84..86; 92..94; 103..111; 116..127; 134..138; 143..147; 155..162; 164..170; 172..175; 180..189; 194..203
3D Structure
NMR spectroscopy (3); X-ray crystallography (4)

Domain & Motif Annotations

Compositional Bias
243..262; Basic and acidic residues; 269..280; Polar residues; 326..338; Pro residues
Domain (FT)
25..128; Ig-like V-type; 129..209; Ig-like C2-type
Region
61..75; CD58 binding region 1; 106..120; CD58 binding region 2; 237..351; Disordered
Clinical Relevance
Disease Involvement
FDA approved drug targets
Related Diseases
Biomarker
Phase 2; Discontinued in Phase 2
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000140368ENSG00000147010ENSG00000169217ENSG00000198087
Interaction Count
4
Interaction Dataset
intact_biogrid